| Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara J Schneider, SC Gilbert, TJ Blanchard, T Hanke, KJ Robson, CM Hannan, ... Nature medicine 4 (4), 397-402, 1998 | 863 | 1998 |
| Effective induction of simian immunodeficiency virus-specific cytotoxic T lymphocytes in macaques by using a multiepitope gene and DNA prime-modified vaccinia virus Ankara … T Hanke, RV Samuel, TJ Blanchard, VC Neumann, TM Allen, JE Boyson, ... Journal of virology 73 (9), 7524-7532, 1999 | 398 | 1999 |
| Direct assessment of MHC class I binding by seven Ly49 inhibitory NK cell receptors T Hanke, H Takizawa, CW McMahon, DH Busch, EG Pamer, JD Miller, ... Immunity 11 (1), 67-77, 1999 | 394 | 1999 |
| HIV vaccines 1983–2003 AJ McMichael, T Hanke Nature medicine 9 (7), 874-880, 2003 | 374 | 2003 |
| Design and pre-clinical evaluation of a universal HIV-1 vaccine S Letourneau, EJ Im, T Mashishi, C Brereton, A Bridgeman, H Yang, ... PloS one 2 (10), e984, 2007 | 324 | 2007 |
| Viral infections induce abundant numbers of senescent CD8 T cells D Voehringer, C Blaser, P Brawand, DH Raulet, T Hanke, H Pircher The Journal of Immunology 167 (9), 4838-4843, 2001 | 317 | 2001 |
| Induction of AIDS virus-specific CTL activity in fresh, unstimulated peripheral blood lymphocytes from rhesus macaques vaccinated with a DNA prime/modified vaccinia virus … TM Allen, TU Vogel, DH Fuller, BR Mothe, S Steffen, JE Boyson, T Shipley, ... The Journal of Immunology 164 (9), 4968-4978, 2000 | 316 | 2000 |
| Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime T Hanke, TJ Blanchard, J Schneider, CM Hannan, M Becker, SC Gilbert, ... Vaccine 16 (5), 439-445, 1998 | 305 | 1998 |
| Selective targeting of regulatory T cells with CD28 superagonists allows effective therapy of experimental autoimmune encephalomyelitis N Beyersdorf, S Gaupp, K Balbach, J Schmidt, KV Toyka, CH Lin, T Hanke, ... The Journal of experimental medicine 202 (3), 445-455, 2005 | 262 | 2005 |
| A human immunodeficiency virus 1 (HIV-1) clade A vaccine in clinical trials: stimulation of HIV-specific T-cell responses by DNA and recombinant modified vaccinia virus Ankara … M Mwau, I Cebere, J Sutton, P Chikoti, N Winstone, EGT Wee, T Beattie, ... Journal of general virology 85 (4), 911-919, 2004 | 262 | 2004 |
| Induction of multifunctional human immunodeficiency virus type 1 (HIV-1)-specific T cells capable of proliferation in healthy subjects by using a prime-boost regimen of DNA-and … N Goonetilleke, S Moore, L Dally, N Winstone, I Cebere, A Mahmoud, ... Journal of virology 80 (10), 4717-4728, 2006 | 261 | 2006 |
| Topological requirements and signaling properties of T cell–activating, anti-CD28 antibody superagonists F Lühder, Y Huang, KM Dennehy, C Guntermann, I Müller, E Winkler, ... The Journal of experimental medicine 197 (8), 955-966, 2003 | 261 | 2003 |
| Design and construction of an experimental HIV-1 vaccine for a year-2000 clinical trial in Kenya. T Hanke, AJ McMichael Nature medicine 6 (9), 951-955, 2000 | 257 | 2000 |
| Vaccine-elicited human T cells recognizing conserved protein regions inhibit HIV-1 N Borthwick, T Ahmed, B Ondondo, P Hayes, A Rose, U Ebrahimsa, ... Molecular therapy 22 (2), 464-475, 2014 | 241 | 2014 |
| Quantitative, wide-spectrum kinase profiling in live cells for assessing the effect of cellular ATP on target engagement JD Vasta, CR Corona, J Wilkinson, CA Zimprich, JR Hartnett, MR Ingold, ... Cell chemical biology 25 (2), 206-214. e11, 2018 | 237 | 2018 |
| Crystal structure of a soluble CD28-Fab complex EJ Evans, RM Esnouf, R Manso-Sancho, RJC Gilbert, JR James, C Yu, ... Nature immunology 6 (3), 271-279, 2005 | 227 | 2005 |
| CD28‐mediated induction of proliferation in resting T cells in vitro and in vivo without engagement of the T cell receptor: Evidence for functionally distinct forms of … M Tacke, G Hanke, T Hanke, T Hünig European journal of immunology 27 (1), 239-247, 1997 | 219 | 1997 |
| DNA multi-CTL epitope vaccines for HIV and Plasmodium falciparum: immunogenicity in mice T Hanke, J Schneider, SC Gilbert, AVS Hill, A McMichael Vaccine 16 (4), 426-435, 1998 | 211 | 1998 |
| Cutting edge: identification of E-cadherin as a ligand for the murine killer cell lectin-like receptor G1 C Gründemann, M Bauer, O Schweier, N von Oppen, U Lässing, ... The Journal of Immunology 176 (3), 1311-1315, 2006 | 204 | 2006 |
| Protection in dogs against visceral leishmaniasis caused by Leishmania infantum is achieved by immunization with a heterologous prime-boost regime using DNA and vaccinia … MJ Ramiro, JJ Zárate, T Hanke, D Rodriguez, JR Rodriguez, M Esteban, ... Vaccine 21 (19-20), 2474-2484, 2003 | 195 | 2003 |
